PD-1 Blocker Safe in Childhood Cancers. But Does It Work?

]]>(MedPage Today) -- PD-1-directed immunotherapy was safe and tolerable in children and adolescents with previously treated cancers, though responses were limited to those with lymphoma, a phase I/II study found.Four of 20 evaluable lymphoma patients...